Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of Vorinostat Concurrent With Stereotactic Radiotherapy in Treatment of Brain Metastases From Non-Small Cell Lung Cancer

NCT00946673 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT00946673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00946673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of Vorinostat Concurrent With Stereotactic Radiotherapy in Treatment of Brain Metastases From Non-Small Cell Lung Cancer
Lead sponsor
Stanford University
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2009
Completion date
July 31, 2015
Enrollment
17 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain cancer, carcinoma, non-small-cell lung, lung cancer, neoplasm metastasis